75K consumer records accessed on ACA exchanges in data breach

The files of approximately 75,000 individuals were accessed during suspicious activity in the Affordable Care Act enrollment system, according to CMS. The agency stated it took immediate steps to secure the system.

The Direct Enrollment pathway, which was launched in 2013, enables brokers and consumers to help consumers enroll in healthcare plans on the Federally Facilitated Exchanges.

CMS began investigating the incident on Oct. 13 and declared the breach on Oct. 16. The agent and broker accounts associated with the breach were deactivated, and CMS disabled the Direct Enrollment pathway for agents and brokers, according to the agency.

“Our number one priority is the safety and security of the Americans we serve. We will continue to work around the clock to help those potentially impacted and ensure the protection of consumer information,” CMS Administrator Seema Verma said in a statement. “I want to make clear to the public that HealthCare.gov and the Marketplace Call Center are still available, and open enrollment will not be negatively impacted. We are working to identify the individuals potentially impacted as quickly as possible so that we can notify them and provide resources such as credit protection."

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.